Primary objective
The primary objective of this study is to evaluate the rate of successful drug selection by using drug screens in PDO generated from patients with low grade intermediate-risk NMIBC. This will allow to determine the rate of patients in which drug selection can successfully be performed for adjuvant intravesical instillation therapies.